Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ABBV-319
i
Other names:
ABBV-319
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
AbbVie
Drug class:
CD19-targeted antibody-drug conjugate, GCR modulator
Related drugs:
‹
loncastuximab tesirine-lpyl (7)
SGN-CD19B (5)
IKS03 (2)
OXS-1550 (0)
SAR3419 (0)
SGN-CD19A (0)
loncastuximab tesirine-lpyl (7)
SGN-CD19B (5)
IKS03 (2)
OXS-1550 (0)
SAR3419 (0)
SGN-CD19A (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login